Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Levy Richard S
Relationship:  
City:   Wilmington
State:   DE
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   67,748    

Indirect Shares

   0      
Direct Value   $3,274,842    

Indirect Value

   $0      
Total Shares   67,748      
Total Value   $3,274,842      


Incyte Corp $898,094 Madrigal Pharmaceuticals Inc $2,113,665 Protara Therapeutics, Inc $93,000 Kodiak Sciences Inc. $3,610 Kiniksa Pharmaceuticals, Ltd. $166,474 Incyte Corp $898,094 Madrigal Pharmaceuticals Inc $2,113,665 Protara Therapeutics, Inc $93,000 Kodiak Sciences Inc. $3,610 Kiniksa Pharmaceuticals, Ltd. $166,474
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   195.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY EVP, Chief Drug Dev Of... 2016-01-06 16,926 2010-03-15 0    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-04-01 10,298 2017-08-21 0    Premium*  
            Protara Therapeutics, Inc TARA Director 2020-01-10 31,000 2020-01-10 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-03-20 1,000 2020-03-20 0    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 2024-05-03 8,524 2023-06-29 0    Premium*  
* Premium Members only  

Records found :    81         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KNSA Kiniksa Pharmaceuticals, ...   –       •      –    2023-06-29 4 OE $0.00 $0 D/D 5,000 5,000 0 -
KNSA Kiniksa Pharmaceuticals, ...   –       •      –    2023-11-03 4 OE $0.00 $0 D/D 2,777 7,777 0 -
MDGL Madrigal Pharmaceuticals ...   –       •      –    2024-04-01 4 AS $255.90 $2,832,335 D/D (11,000) 10,298 0 %
MDGL Madrigal Pharmaceuticals ...   –       •      –    2024-04-01 4 OE $7.36 $703,160 D/D 11,000 21,298 0 -
KNSA Kiniksa Pharmaceuticals, ...   –       •      –    2024-05-03 4 OE $0.00 $0 D/D 747 8,524 0 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2017-08-21 4 B $15.67 $56,358 D/D 3,550 3,550 2.39 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2017-08-22 4 B $15.99 $57,209 D/D 3,550 7,100 2.39 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2017-08-23 4 B $16.08 $32,236 D/D 2,000 9,100 2.39 -
TARA Protara Therapeutics, Inc Director   –       •      –    2020-01-10 4 A $0.00 $0 D/D 31,000 31,000 0 -
KOD Kodiak Sciences Inc. Director   –       •      –    2020-03-20 4 B $43.37 $44,330 D/D 1,000 1,000 2.39 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-01-17 4 OE $100.45 $2,316,844 D/D 22,489 31,589 0 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-01-17 4 AS $285.28 $6,592,686 D/D (22,489) 9,100 0 %
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-03-06 4 AS $89.91 $2,247,750 D/D (25,000) 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-03-06 4 OE $18.32 $458,000 D/D 25,000 46,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-04-06 4 OE $18.32 $458,000 D/D 25,000 46,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-04-06 4 AS $88.77 $2,219,250 D/D (25,000) 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-05-06 4 OE $18.32 $135,788 D/D 7,412 28,639 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-05-06 4 AS $99.43 $736,975 D/D (7,412) 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-06-08 4 AS $107.58 $423,542 D/D (3,937) 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-06-08 4 OE $18.32 $72,126 D/D 3,937 25,164 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-06-19 4 OE $17.79 $355,800 D/D 20,000 41,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-06-19 4 AS $108.13 $2,162,600 D/D (20,000) 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-07-06 4 OE $18.32 $72,126 D/D 3,937 25,164 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-07-06 4 AS $107.00 $421,259 D/D (3,937) 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-07-15 4 AS $120.00 $8,426,040 D/D (70,217) 21,227 0 -
  81  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us